Fermenta Biotech Ltd. (FERMENTA): Fermenta Biotech Share Price rises 8.73% to Rs 519 on 29 September 2026
- September 29, 2026
- Posted by: Harsh Piplani
- Category: News
Fermenta Biotech Share Price rose 8.73% today to Rs 519, adding Rs 41.65 from the previous close of Rs 477.35. The company’s market capitalisation now stands at Rs 1,377.81 crore, placing Fermenta Biotech Ltd. in today’s stock news flow as a notable share price gain in the healthcare segment. The move is verified by the supplied price data, but the data does not establish a company-specific catalyst. For readers tracking Fermenta Biotech Share Price Today, the key points are the higher close, the day’s range between Rs 496.35 and Rs 519, and turnover of Rs 0.58 crore. Univest is monitoring the same-day price rise alongside the company’s valuation, sector benchmark and peer comparison so investors can place the move in context. If you are following Fermenta Biotech Stock News or Fermenta Biotech Share Price Live, today’s numbers provide the factual base for that review.
Fermenta Biotech Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 519 |
| Previous Close | Rs 477.35 |
| Today's Move | Rs 41.65 (+8.73%) |
| Open | Rs 499.1 |
| High | Rs 519 |
| Low | Rs 496.35 |
| Turnover | Rs 0.58 crore |
| Market Capitalisation | Rs 1,377.81 crore |
| Market Cap Category | Small Cap |
Fermenta Biotech Ltd. (FERMENTA) rose to Rs 519 from the previous close of Rs 477.35, a move of Rs 41.65 or 8.73%. The stock opened at Rs 499.1, reached a high of Rs 519, recorded a low of Rs 496.35.
Fermenta Biotech Share Price Today moved from an open of Rs 499.1 to a high of Rs 519, with a low of Rs 496.35 and a close at the day’s high of Rs 519. The stock rose Rs 41.65, or 8.73%, over the previous close of Rs 477.35. This was a clear same-day price rise, and the supplied data confirms the event without naming a specific trigger. Turnover stood at Rs 0.58 crore, which is the factual traded-value context available for the session. Fermenta Biotech Share Price Update readers can use these figures to understand the day’s range, the closing level and the size of the move. In Fermenta Biotech Stock News, the move is significant because the close held at the upper end of the day’s range, while the event itself remains limited to the verified price action.
Fermenta Biotech Ltd. (FERMENTA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,377.81 crore |
| P/E Ratio | 23.23x |
| P/B Ratio | 3.4x |
| ROE | 18.36% |
| ROCE | 21.99% |
| EPS | Rs 20.55 |
| Book Value Per Share | Rs 140.3 |
| Dividend Yield | 0.79% |
Fermenta Biotech Ltd. (FERMENTA) fundamental metrics show P/E 23.23x, P/B 3.4x, ROE 18.36%, ROCE 21.99%. These figures provide context only and are not a buy or sell signal.
Fermenta Biotech Ltd. has a market capitalisation of Rs 1377.81 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 23.23x, P/B at 3.4x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.36% and ROCE of 21.99%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 20.55, book value per share of Rs 140.3, dividend yield of 0.79%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.59x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 23.23x |
| Benchmark Median P/E | 32.59x |
| Benchmark Average P/E | 49x |
| Benchmark P/E Range | 3.46x to 707.31x |
| Company P/B Ratio | 3.4x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 18.36% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 21.99% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 1,377.81 crore |
| Benchmark Median Market Cap | Rs 783.26 crore |
Fermenta Biotech Ltd. (FERMENTA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Fermenta Biotech Ltd. (FERMENTA) has a P/E ratio of 23.23x, which is below the benchmark median of 32.59x, a difference of -28.72%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Fermenta Biotech Ltd. (FERMENTA) has a ROE of 18.36%, which is above the benchmark median of 11.7%, a difference of +56.92%. Fermenta Biotech Ltd. (FERMENTA) has a ROCE of 21.99%, which is above the benchmark median of 13.61%, a difference of +61.57%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 36.5 | 5.1 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,55,115.31 | 86.51 | 14.33 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,613.38 | 84.92 | 20.64 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,19,899.96 | 26.79 | 4.48 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,12,875.68 | 33.29 | 3.19 | 11.83 | 16 |
Fermenta Biotech Ltd. (FERMENTA) has a P/E ratio of 23.23x compared with the displayed peer median of 36.5x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.36% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 21.99% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Fermenta Biotech Ltd. (FERMENTA) has a market capitalisation of Rs 1,377.81 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Fermenta Biotech
- Fermenta Biotech Share Price rose 8.73% today to Rs 519, with a gain of Rs 41.65 over the previous close of Rs 477.35.
- The day’s price range was Rs 496.35 to Rs 519, and the stock closed at the high for the session.
- Market capitalisation is Rs 1,377.81 crore, which places the company above the industry median market cap of Rs 783.26 crore.
- P/E is 23.23, P/B is 3.4, ROE is 18.36% and ROCE is 21.99%, giving clear valuation and profitability context.
- EPS is Rs 20.55, book value is Rs 140.3 and dividend yield is 0.79%, which are the key per-share metrics in Fermenta Biotech Fundamental Analysis.
About Fermenta Biotech
Fermenta Biotech Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data does not include a business description, segment split or revenue mix, so the factual company context available here is limited to its listed identity and sector position. Even so, Fermenta Biotech Share Price can still be interpreted through the metrics available today: market capitalisation, valuation, profitability and peer positioning. For readers using Fermenta Biotech Stock Analysis, the company belongs to a competitive industry where return ratios and valuation multiples often matter as much as the day’s share price move. Univest presents Fermenta Biotech Company News in a way that keeps the focus on verified market data, not assumptions. That makes the current Fermenta Biotech Share Price Update useful for both quick reading and deeper screening.
Track Fermenta Biotech Share Price on Univest
Use Fermenta Biotech Ltd. (FERMENTA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Fermenta Biotech Share Price rise today?
Ans. The supplied data confirms an 8.73% same-day rise to Rs 519, but it does not establish a company-specific catalyst. The session also showed a high of Rs 519 and turnover of Rs 0.58 crore.
What is Fermenta Biotech Share Price today?
Ans. Fermenta Biotech Share Price today is Rs 519. It moved up Rs 41.65 from the previous close of Rs 477.35, making the day’s gain 8.73% on the verified price data.
What is Fermenta Biotech market capitalisation?
Ans. Fermenta Biotech market capitalisation is Rs 1,377.81 crore. That figure places the company above the industry median market cap of Rs 783.26 crore in the supplied same-industry benchmark. The company operates in the Healthcare sector.
How does Fermenta Biotech look on valuation?
Ans. Fermenta Biotech has a P/E of 23.23 and a P/B of 3.4. Both can be compared with the same-industry median and peer values to place the stock’s valuation in context.
What do Fermenta Biotech ROE and ROCE show?
Ans. ROE is 18.36% and ROCE is 21.99%. These figures show return on equity and capital employed, and both sit above the industry medians in the supplied benchmark. ROE stands at 18.36%.
What do EPS, book value and dividend yield mean for Fermenta Biotech?
Ans. EPS is Rs 20.55, book value is Rs 140.3 and dividend yield is 0.79%. EPS measures earnings per share, book value shows accounting net worth, and dividend yield reflects historical payout data.
How does Fermenta Biotech compare with peers?
Ans. Fermenta Biotech’s P/E is below Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla. Its ROE and ROCE compare favourably with several peers in the supplied list. Comparable listed companies include Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd., Torrent.
Where does Fermenta Biotech operate?
Ans. Fermenta Biotech operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data provides this sector placement, which is useful for reading the company’s valuation and peer context.
